Breaking: Government Trial Shows Efficacy for Remdesivir in COVID Infection

Posted byjbakerjrblogPosted inArticles / Impressions, Repurposing Drugs

A placebo-controlled, government run trial of remdesivir to treat COVID-19 infection reportedly met its “primary efficacy endpoint” according to Gilead Sciences. While we are waiting for more information on the results, having shown efficacy in this large (800 patient), controlled trial could help to resolve the questions raised in prior testing of the drug.

More to come….

Published by jbakerjrblog

Immunologist, former Army MD, former head of allergy and clinical immunology at University of Michigan, vaccine developer and opinionated guy.

One thought on “Breaking: Government Trial Shows Efficacy for Remdesivir in COVID Infection”

Leave a comment